The era of GLP-1 receptor agonists: costs versus benefits
用户k7g3AjDeE8DM
2个月前
132
10
已关闭
DOI: 10.1016/S2213-8587(24)00376-0
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858724003760
其他信息:
出版社: Elsevier BV
作者: undefined The Lancet Diabetes & Endocrinology